does masshealth cover semaglutide Changes for Weight-Loss Treatment Rhode Island considers ending Medicaid

Gastric emptying is the process by which food moves from your stomach into your small intestine

GLP-1RAs have effects on systemic inflammation such as reduction in high-sensitivity C-reactive protein (hs-CRP) that are not mediated by weight loss or glycemic control [15, 27, 28]

GLP-1 is a natural substance in the stomach that helps keep blood sugar and hunger in check

Semaglutide was granted approval by the FDA in early 2023 as an obesity treatment in pediatric populations aged 12 and above [6, 7]

The decision to choose a specific medication should be made after a thorough discussion with healthcare professionals, taking into consideration the unique health profiles and goals of each patient